AUDIT REPORT NO. 9-000-11-001-P | February 24, 2011
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
Lignes directrices.
Collection Avis et Rapports.
Manual for Early Implementation
Therapeutics Information and Pharmacovigilance Centre | TIPC
What We Know, What We Don’t Know, and What We Need to Do